Dr. Keith Powell
Chief Executive Officer; been with PolyTherics since 2005. With extensive experience in the management of large and small biotech companies, he successfully led SPEAR into an $8.5M series B financing round. Prior to PolyTherics, Keith was responsible for the execution of research partnerships at Maxygen which generated >$20M of revenue before milestones and royalties.
Dr. Antony Godwin
Head of Chemistry, co-founder of PolyTherics. Co-inventor of four PolyTherics patents.
Dr. Ji-won Choi
Head of Biology; brings expertise in biological assays and validations. Co-inventor of two of PolyTherics patents.
Professor Sunil Shaunak, MD PhD
Chairman of the Scientific Advisory Board; Co-founder of PolyTherics and holds a position as Professor of Infectious Diseases at the Hammersmith Hospital, Imperial College London.
Professor Steve Brocchini
Chief Scientific Officer; co-founder of PolyTherics and heads the Biomedical Polymer Group as a Professor at the London School of Pharmacy.
Dr. Debbie Allen
Responsible for PolyTherics' Business Development in the area of biotherapeutics. Debbie has extensive experience in the field of therapeutic antibodies and was most recently responsible for business development at Cambridge Antibody Technology.
Sitemap | Privacy Policy | Terms of Use
